Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Gastrointestinal Stromal Tumors (GIST)”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Testing effectiveness (Phase 2)Study completedNCT03609424
What this trial is testing

PDR001 Plus Imatinib for Metastatic or Unresectable GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 39
Early research (Phase 1)Active Not RecruitingNCT05489237
What this trial is testing

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal NeoplasmsGastrointestinal Stromal Tumor (GIST)Digestive System Disease+2 more
IDRX, Inc., a wholly owned subsidiary of GSK, LLC 276
Not applicableStudy completedNCT02106858
What this trial is testing

Stivarga Regulatory Post-Marketing Surveillance Study in Korea

Who this might be right for
Colorectal Neoplasms
Bayer 316
Not applicableUnknownNCT05132738
What this trial is testing

Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy

Who this might be right for
Gastrointestinal Stromal Tumors
RenJi Hospital 20
Post-approval studies (Phase 4)Study completedNCT00756509
What this trial is testing

Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 34
Testing effectiveness (Phase 2)Study completedNCT01323400
What this trial is testing

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
GIST
Centre Leon Berard 81
Not applicableStudy completedNCT00976612
What this trial is testing

Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT01874665
What this trial is testing

Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor

Who this might be right for
GIST
Ariad Pharmaceuticals 45
Early research (Phase 1)Study completedNCT00276302
What this trial is testing

Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)

Who this might be right for
Gastrointestinal Stromal TumorsSoft Tissue Sarcomas
Infinity Pharmaceuticals, Inc. 63
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT05895942
What this trial is testing

Exploring the Molecular Mechanism Based on KIT Mutation

Who this might be right for
GIST
Xijing Hospital 190
Not applicableActive Not RecruitingNCT05038254
What this trial is testing

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Who this might be right for
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+42 more
M.D. Anderson Cancer Center 750
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Post-approval studies (Phase 4)Study completedNCT01735955
What this trial is testing

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Who this might be right for
Chronic Myelogenous Leukemia (CML)Metastatic Gastrointestinal Stromal Tumors (GIST)Acute Lymphoblastic Leukemia (ALL)+1 more
Novartis Pharmaceuticals 57
Large-scale testing (Phase 3)Study completedNCT00785785
What this trial is testing

Nilotinib Versus Imatinib in GIST Patients

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Novartis Pharmaceuticals 644
Testing effectiveness (Phase 2)Study completedNCT01068769
What this trial is testing

Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
Suzanne George, MD 34
Testing effectiveness (Phase 2)Study completedNCT00004910
What this trial is testing

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+6 more
Northwestern University
Not applicableStudy completedNCT01265979
What this trial is testing

WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib

Who this might be right for
Gastrointestinal Stromal Tumors
Universitaire Ziekenhuizen KU Leuven 5
Large-scale testing (Phase 3)Ended earlyNCT00812240
What this trial is testing

Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
AB Science 335
Testing effectiveness (Phase 2)Study completedNCT02401815
What this trial is testing

CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc. 51
Next Page